All Stories

  1. LncRNA CRNDE is downregulated and associated with poor prognostic markers in chronic lymphocytic leukemia
  2. Biomedical impact of the expression of HOX locus-associated LncRNAs HOTAIR and HOTTIP in diffuse large B cell lymphoma
  3. Poster: ABCL-007 Semiquantitative Measurements of Standard-Uptake-Value (ΔSUV) in Assessment of Patients Response and Outcomes in Aggressive Lymphomas
  4. Long Non-Coding RNAs ASB16-AS1 and AFAP1-AS1: Diagnostic, Prognostic Impact and Survival Analysis in Colorectal Cancer
  5. LncRNA CCAT2 expression at diagnosis predicts imatinib response in chronic phase chronic myeloid leukemia patients
  6. Are the genetic variants/haplotypes of the CDH1 gene contribute to skin tags and internal malignancies in skin tag subjects? A pilot study
  7. Inverse relationship between the level of miRNA 148a-3p and both TGF-β1 and FIB-4 in hepatocellular carcinoma
  8. miRNA-148a and miRNA-30c expressions as potential biomarkers in breast cancer patients
  9. Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial
  10. The prognostic impact of Wilms tumor-1 polymorphism (rs16754) and human myeloid inhibitory C-type lectin-like receptor expression in cytogenetically normal-acute myeloid leukemia
  11. Biochemical and molecular study of long non-coding RNAs (HOTTIP, ZEB-AS1 and MEG-3) in hepatocellular carcinoma
  12. Burnout and work stress among medical oncologists: Egyptian multi-centric study
  13. Anxiety, depression and perceived stress among breast cancer patients: single institute experience
  14. Association Between the ACE (I/D) Gene Polymorphism and Hepatocellular Carcinoma Risk in Egyptian HCV Patients
  15. Paclitaxel as a possible continuation maintenance therapy in advanced non-small-cell lung cancer
  16. Evaluation of ASPM and TEF Gene Expressions as Potential Biomarkers for Bladder Cancer
  17. Workplace-related stress among oncologists: Egyptian single-centered observational study
  18. PARP inhibition increases immune infiltration in homologous recombination repair (HRR)-deficient tumors
  19. Detection of Double Protein Expression in Diffuse Large B-Cell Lymphoma (DLBCL) A Single Center Study
  20. Paclitaxel for the treatment of anal cancer after cisplatin and 5-fluorouracil
  21. Potential value of circulatory microRNA122 gene expression as a prognostic and metastatic prediction marker for breast cancer
  22. Diagnostic value of platelet indices, carbohydrate antigen 19-9 and carcinoembryonic antigen in differentiating malignant from benign gastric ulcers
  23. The clinical impact of miRNA34a and P53 gene expression in colon cancer
  24. 1ODifferences in prognosis and efficacy of chemotherapy by p53 expression in triple negative breast cancer
  25. Clinical Value of C-reactive Protein and Erythrocyte Sedimentation Rate in Advanced Bladder Cancer
  26. Clinical Value of Serum Neopterin in Breast Cancer
  27. 1004OFinal overall survival results of frontline bortezomib plus rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) vs R-CHOP in transplantation-ineligible patients (pts) with newly diagnosed mantle-cell lymphoma (MCL): A randomized, ope...
  28. fibrinogen in lymphoma
  29. Potential role of MicroRNA 200c gene expression in assessment of colorectal cancer
  30. Clinical Features and Outcomes of Carcinoma of Unknown Primary Site: A Single Center Experience
  31. Does GLUT-1 have a Role in Prognosis of Breast Carcinoma of Egyptian Patients?
  32. Clinical Outcome of Exocrine Pancreatic Adenocarcinoma: A Single Center Experience
  33. Validity and clinical impact of glucose transporter 1 expression in colorectal cancer
  34. Effect of Body Mass Index on Survival in Patients with Epithelial Ovarian Cancer
  35. The diagnostic and prognostic value of CD38 and CD49d expressions in chronic lymphocytic leukemia
  36. Incidence of MRSA infection in pneumonia in cancer patients with phenotyping & genotyping study
  37. Impact of breast surgery on response and survival in metastatic breast cancer patients